Real-time measurement of stimulated 5-hydroxytryptamine release in rat substantia nigra pars reticulata brain slices

Synapse

Volumn 25, Issue 1, 1997, Pages 93-102

  Iravani, Mahmoud M ^a   Kruk, Zygmunt L ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

5 Hydroxy tryptamine; axonal release; carbon fibre electrodes; chemical stimulation; electrical stimulation; fast cyclic voltammetry; substantia nigra pars reticulata

Indexed keywords

4 (4 METHYL 1 PIPERAZINYL) 7 TRIFLUOROMETHYLPYRROLO[1,2 A]QUINOXALINE; METITEPINE; SEROTONIN; SEROTONIN 1B RECEPTOR; VANOXERINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DYSTONIA; MALE; MICROELECTRODE; MOTOR DYSFUNCTION; NERVE ENDING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SUBSTANTIA NIGRA; TARDIVE DYSKINESIA;

EID: 0031021895     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2396(199701)25:1<93::aid-syn11>3.0.co;2-%23     Document Type: Article

References (89)

1. Aghajanian, G.K., Kuhar, M.J., and Roth, R.H. (1973) Serotonin-containing neuronal perikarya and terminals: differential effects of P-chlorophenylalanine. Brain. Res., 54:85-101.
2. Azimitia, E.C., and Segal, M. (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol., 179:641-667.
3. Björklund, A., and Lindvall, O. (1975) Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals. Brain Res., 83:531-537.
4. Blackburn, T.P., Cox, B., Heapy, C.G., Lee, T.F., and Middlemiss, D.N. (1981) Supersensitivity of nigral receptors and rat rotational behaviour. Eur. J. Pharmacol., 71:343-346.
5. Bolam, J.P., and Smith, Y. (1990) The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat. Brain Res., 529:57-78.
6. Borison, R.L., Pathiraja, A.P., and Diamond, B.I. (1992) Influence of serotonin on dopaminergically mediated extrapyramidal side effects. Mov. Disord. 7 (Suppl. 1):55.
7. 1B receptor is localized predominantly on axon terminals. Neuroscience, 58:167-182.
8. Bourgoin, S., Soubrie, P., Artaud, F., Reisine, T.D., and Glowinski, J. (1981) Control of 5-HT release in the caudate nucleus and the substantia nigra of the cat. J. Physiol. (Paris), 77:303-307.
9. 1D binding sites in various species: similar pharmacological profile in dog, monkey, calf, guinea-pig and human brain membranes. Naunyn Schmiedebergs Arch. Pharmacol., 346:243-248.
10. Bruinvels, A.T., Palacios, J.M., and Hoyer, D. (1993) Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain. Naunyn Schmiedebergs Arch. Pharmacol., 347:569-582.
11. Bunney, B.S., and Aghajanian, G.K. (1977) D-amphetamine-induced inhibition of central dopaminergic neurons: direct effect or mediated by a striatonigral feedback pathway? Adv. Biochem. Psychopharmacol., 16:577-582.
12. Bunney, B.S., Walters, J.R., Roth, R.H, and Aghajanian, G.K. (1973) Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharm. Exp. Ther. 185:560-571.
13. Casey, D.E. (1987) Neuroleptic-induced parkinsonism increases with repeated treatment in monkeys. Psychopharmacol. Ser., 3:243-247.
14. Chen, N.H., and Reith, M.E. (1993) [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine. J. Pharmacol. Exp. Ther., 267:379-389.
15. Chéramy, A., Nieoullon, A., and Glowinski, J. (1979) Effects of the unilateral nigral application of baclofen on dopamine release in the two caudate nuclei of the cat. Eur. J. Pharmacol., 58:133-140.
16. Chéramy, A., Leviel, V., and Glowinski, J. (1981) Dendritic release of dopamine in the substantia nigra. Nature, 289:537-542.
17. Chevalier, G., and Deniau, J.M. (1990). Disinhibition as a basic process in the expression of straital functions. Trends Neurosci., 13:277-280.
18. Chopin, P., Moret, C., and Briley, M. (1994) Neuropharmacology of 5-hydroxytryptamine1B/D receptor ligands. Pharmacol. Ther., 62: 385-405.
19. Condé, H. (1992) Organization and physiology of the substantia nigra. Exp. Brain Res., 88:233-248.
20. Corvaja, N., Doucet, G., and Bolam, J.P. (1993) Ultrastructure and synaptic targets of the raphe-nigral projection in the rat. Neuroscience, 55:417-427.
21. 1B receptor in serotoninergic neurons of rat anterior raphé nuclei in the rat brain. Synapse, 19:18-28.
22. Dray, A., Gonye, T.J., Oakley, N.R., and Tanner, T. (1976) Evidence for the existence of a raphe projection to the substantia nigra in the rat. Brain Res., 113:45-57.
23. Dray, A., Davies, J., Oakley, N.R., Tongroach, P., and Vellucci, S. (1978) The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical and behavioural observations. Brain Res., 151:431-442.
24. Fibiger, H.C., and Miller, J.J. (1977) An anatomical and electrophysiological investigation of the serotonergic projection from the dorsal raphe nucleus to the substantia nigra in the rat. Neuroscience, 2:975-987.
25. Fuxe, K., (1965) Evidence for the existence of moboamine neurons in the central nervous system - IV. Distribution of the moamine nerve terminals in the central nervous system. Acta Physiol. Scand., 64:39-85.
26. Geffen, L.B., Jessell, T.M., Cuello, A.C., and Iversen, L.L. (1976) Release of dopamine from dendrites in rat substantia nigra. Nature, 260:258-260.
27. Grace, A.A. (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsibility: a hypothesis for the etiology of schizophrenia. Neuroscience, 41:1-24.
28. Gunne, L.M., and Andren, P.E. (1993) An animal model for coexisting tardive dyskinesia and tardive parkinsonism: a glutamate hypothesis for tardive dyskinesia. Clin. Neuropharmacol., 16:90-95.
29. Hamon, M., Lanfumey, L., El Mestikawy, S., Boni, C., Miquel, M.C., Bolanos, F., Schechter, L., and Gozlan, H. (1990) The main features of central 5-HT1 receptors. Neuropsychopharmacology, 3:349-360.
30. Hefti, F., and Lichtensteiger, W. (1978) Dendritic dopamine: studies on the release of endogenous dopamine from subcellular particles derived from dendrites of rat nigro-striatal neurons. Neurosci. Lett., 10:65-70.
31. Hery, F., Soubrié, P., Bourgoin, S., Monsatruc, J.L., Artaud, F., and Glowinski, J. (1980) Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin. Brain Res., 193:143-151.
32. Hoyer, D., and Middlemiss, D.N. (1989) Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharm. Sci., 10:130-132.
33. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharene, E.J., Saxena, P.R., and Humphrey, P.P.A. (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46:157-203.
34. Iravani, M.M., and Kruk, Z.L. (1995) Effects of amphetamine on carrier-mediated and electrically stimulated dopamine release in slices of rat caudate putamen and nucleus accumbens. J. Neurochem., 64:1161-1168.
35. Iravani, M.M., Millar, J., and Kruk, Z.L. (1994) Dopamine release in the ventral tegmental area and nucleus accumbens compared. J. Physiol., 480:70p.
36. Iravani, M.M., Muscat, R., and Kruk, Z.L. (1996) Comparison of somatodendritic and axon terminal dopamine release in the ventral tegmental area and the nucleus accumbens. Neuroscience, 70:1025-1037.
37. B synaptic potential in the rat dopamine neurons. J. Neurosci., 12:2000-2006.
38. Kalivas, P.W., and Stewart, J. (1991) Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res. Rev, 16:223-244.
39. Kant, G.J., and Meyerhoff, J.L. (1978) Release of endogenous norepinephrine and dopamine from rat brain regions in vitro. Life Sci., 23:2111-2118.
40. Lacey, M.G., Mercuri, N.B., and North, R.A. (1987) Dopamine acts of D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J. Physiol., 392:397-416.
41. Lavoie, B., and Parent, A. (1990) Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. J. Comp. Neurol., 299:1-16.
42. Lavoie, B., Côté, P.-Y., and Parent, A. (1992) Immunohistochemical study of the basal ganglia in normal and parkinsonian monkeys. Adv. Neurol., 58:115-121.
43. 1D in the rabbit and guinea-pig brain cortex. Naunyn Schmiedebergs Arch. Pharmacol., 343: 353-364.
44. Liminga, U., Johnson, A.E., Andren, P.E., and Gunne, L.M. (1993) Modulation of oral movements by intranigral 5-hydroxytryptamine receptor agonists in the rat. Pharmacol. Biochem. Behav., 46: 427-433.
45. Mamounas, L.A., Mullen, C.A., O'Hearn, E., and Molliver, M.E. (1991) Dual serotoninergic projections to forebrain in the rat -morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. Comp. Neurol., 314:558-586.
46. Maura, G., Roccatagliata, E., and Raiteri, M. (1986) Serotonin autoreceptor in rat hippocampus: pharmacological characterization as a subtype of the 5-HT1 receptor. Naunyn Schmiedebergs Arch. Pharmacol., 334:323-326.
47. Middlemiss, D.N., Bremer, M.E., and Smith, S.M. (1988) A pharmacological analysis of the 5-HT receptor mediating inhibition of 5-HT release in the guinea-pig frontal cortex. Eur. J. Pharmacol., 157:101-107.
48. Moret, C., and Briley, M. (1995) In-vitro and in-vivo activity of 1-(1-naphthyl) piperazine at terminal 5-HT autoreceptors in guinea-pig brain. Naunyn Schmiedebergs Arch. Pharmacol., 351:377-384.
49. Mori, S., Matsuura, T., Takino, T., and Sano, Y. (1987) Light and electron microscopic immunohistochemical studies of serotonin nerve fibers in the substantia nigra of the rat, cat and monkey. Anat. Embryol. (Berl.), 176:13-18.
50. Nakahara, D., Maruyama, W., Hashiguti, H., and Naoi, M. (1994) Characterization of the in-vivo action of (R)-salsolinol, an endogenous metabolite of alcohol, on serotonin and dopamine metabolism - a microdialysis study. Brain Res., 644:226-232.
51. Nedergaard, S., Bolam, J.P., and Greenfield, S.A. (1988) Facilitation of a drendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra. Nature, 333:174-177.
52. Nieoullon, A., Chéramy, A., and Glowinski, J. (1977) Release of dopamine in vivo from cat substantia nigra. Nature, 266:375-377.
53. Nissbrandt, H., Sundstöm, E., Jonsson, G., Hjorth, S., and Carlsson, A. (1989) Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacta, pars reticulata, and striaturn. J. Neurochem., 52:1170-1182.
54. Nissbrandt, H., Waters, N., and Hjorth, S. (1992) The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn Schmiedebergs Arch. Pharmacol., 346:12-19.
55. O'Connor, J.J., and Kruk, Z.L. (1991a) Fast cyclic voltammetry can be used to measure stimulated endogenous 5-hydroxytryptamine release in untreated rat brain slices. J. Neurosci. Methods, 38:25-33.
56. O'Connor, J.J., and Kruk, Z.L. (1991b) Frequency dependence of 5-HT autoreceptor function in rat dorsal raphe and suprachiasmatic nuclei studied using fast cyclic voltammetry. Brain Res., 568: 123-130.
57. O'Connor, J.J., and Kruk, Z.L. (1992) Pharmacological characteristics of 5-hydroxytryptamine autoreceptors in rat brain slices incorporating the dorsal raphe or the suprachiasmatic nucleus. Br. J. Pharmacol., 106:524-532.
58. O'Connor, J.J., and Kruk, Z.L. (1994) Effects of 21 days treatment with fluoxetine on stimulated endogenous 5-hydroxytryptamine overflow in the rat dorsal raphe and suprachiasmatic nucleus studied using fast cyclic voltammetry in vitro. Brain Res., 640:328-335.
59. Palij, P., Bull, D.R., Sheehan, M.J., Stamford, J. Kruk, Z.L., and Humphrey, P.P.A. (1990) Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry. Brain Res., 509:172-174.
60. Palkovits, M., Brownstein, M., and Saavedra, J.M. (1974) Serotonin content of the brain stem nuclei in the rat. Brain Res., 80:237-249.
61. Paxinos, G., and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
62. Pazos, A., and Palacios, J.M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res., 346:205-230.
63. Reisine, T., Soubrié, P., Artaud, F., and Glowinski, J. (1982) Application of L-glutamic acid and substance P to the substantia nigra modulated in vivo 3H-release in the basal ganglia of the cat. Brain Res., 236:317-328.
64. Reubi, J.C., and Emson, P.C. (1978) Release and distribution of endogenous 5-HT in rat substantia nigra. Brain Res., 139:164-168.
65. Reubi, J.C., Emson, P.C., Jessell, T.M., and Iversen, L.L. (1978) Effects of GABA, dopamine, and substance P on the release of newly synthesized 3H-5-hydroxytryptamine from rat substantia nigra in vitro. Naunyn Schmiedebergs Arch. Pharmacol., 304:271-275.
66. Rice, M.E., Richards, C.D., Nedergaard, S., Hounsgaard, J., Nicholson, C., and Greenfield, S.A. (1994) Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro. Exp. Brain Res., 100:395-406.
67. Robertson, G.S., Damsma, G., and Fibiger, H.C. (1991) Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. J. Neurosci., 11:2209-2216.
68. Robertson, H.A., and Robertson, G.S. (1989) Combined levodopa and bromocriptine therapy for Parkinson's disease: evidence suggesting that levodopa acts at sites in the substantia nigra pars reticulata, In: Crossman A.R. and Sambrook, M.A., London, pp. 223-228.
69. Saavedra, J.M., and Axelrod, J. (1974) Enzymatic-isotopic micromethods for the measurement of biogenic amines in brain tissue and body fluids. J. Psychiatr. Res., 11:289-291.
70. Santiago, M., and Westerink, B.H.C. (1991) Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats. J. Neurochem., 57:738-747.
71. Sinton, C.M., and Fallon, S.L. (1988) Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptors. Eur. J. Pharmacol., 157:173-181.
72. Soubrié, P., Montsatruc, J.L., Bourgoin, S., Reisine, T., Artaud, F., and Glowinski, J. (1981) In vivo evidence for GABAergic control of serotonin release in the cat substantia nigra. Eur. J. Pharmacol., 69:483-488.
73. Soubrié, P., Reisine, T.D., and Glowinski, J. (1984) Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull canula technique. Neuroscience, 13:605-625.
74. Stamford, J.A., Kruk, Z.L., and Millar, J. (1990) Striatal dopamine terminals release serotonin after 5-HTP pretreatment: in vivo voltammetric data. Brain Res., 515:173-180.
75. Steinbüsch, H.W.M. (1981) Distribution of serotonin-immunoreactivity in the central nervous system of the rat cell bodies and terminals. Neuroscience, 6:557-618.
76. Stewart, J., and Vezina, P. (1989) Microinjections of Sch-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 495:401-406.
77. Streit, P. (1980) Selective retrograde labeling the transmitter of neuronal pathways. J. Comp. Neurol., 191:429-463.
78. Sulzer, D., Chen, T.-K., Lau, Y.Y., Kristensen, H., Rayport, S., and Ewing, A. (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci., 15:4102-4108.
79. Tågerud, S.E., and Cuello, A.C. (1979) Dopamine release from the rat substantia nigra in vitro. Effect of raphe lesions and veratridine stimulation. Neuroscience, 4:2021-2029.
80. Trent, F., and Tepper, J.M. (1991) Dorsal raphe stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo. Exp. Brain Res., 84:620-630.
81. Trout, S.J., and Kruk, Z.L. (1992) Differences in evoked dopamine efflux in rat caudate putamen, nucleus accumbens and tuberculum olfactorium in the absence of uptake inhibition: influence of autoreceptors. Br. J. Pharmacol., 106: 452-458.
82. Trout, S.J., Patel, J., and Kruk, Z.L. (1992) Monoamine efflux evoked by electrical stimulation in rat brain slices containing substantia nigra and ventral tegmental area. Br. J. Pharmacol., 107:217P.
83. Vezina, P. (1993) Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res. 605:332-337.
84. Vezina, P., Hervé, D., Glowinski, J., and Tassin, J.P. (1994) Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat. Neurosci. Lett., 168:111-114.
85. Waddington, J.L. (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: pharmacology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology, 101:431-447.
86. Waeber, C., and Palacios, J.M. (1992) Non 5-HT1A/5-HT1C [3H]5-HT binding sites in the hamster, opossum, and rabbit brain show similar regional distribution but different sensitivity to beta-adrenoceptor antagonists. Synapse, 12:261-270.
87. Wassef, M., Berod, A., and Sotelo, C. (1981) Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal imput. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration. Neuroscience, 6: 2125-2139.
88. Westerink, B.H., Santiago, M., and De-Vries, J.B. (1992) The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat. Naunyn Schmiedebergs Arch. Pharmacol., 345:523-529.
89. Williams, J., and Davies, J.A. (1983) The involvement of 5-hydroxytryptamine in the release of dendritic dopamine from slices of rat substantia nigra. J Pharm. Pharmacol., 35:734-737.